Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Dementia | Research

Healthcare and community stakeholders’ perceptions of barriers and facilitators to implementing a behavioral activation intervention for people with dementia and depression: a qualitative study using Normalization Process Theory

Authors: Frida Svedin, Oscar Blomberg, Anders Brantnell, Paul Farrand, Anna Cristina Åberg, Joanne Woodford

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Depression is commonly experienced by people with dementia, and associated with lower quality of life and functional decline. However, access to evidence-based psychological interventions for people with dementia and depression is limited. One potential solution is guided low-intensity behavioral activation. Following the new Medical Research Council Framework, considering factors such as potential barriers and facilitators to implementation is recommended during the development of new interventions. Aims of this study were to: (1) develop an understanding of existing healthcare and community support in the Swedish context for people with dementia and their informal caregivers; and (2) identify barriers and facilitators to intervention uptake informed by Normalization Process Theory.

Methods

Semi-structured interviews and focus groups were held with healthcare (n = 18) and community (n = 7) stakeholders working with people with dementia and/or informal caregivers. Interview questions were informed by Normalization Process Theory. Data was analysed utilizing a two-step deductive analysis approach using the Normalization Process Theory coding manual, with inductive categories applied to data related to the main mechanisms of the theory, but not captured by its sub-constructs.

Results

Ten deductive and three inductive categories related to three Normalization Process Theory primary mechanisms (Coherence, Cognitive Participation, and Collective Action) were identified. Identified barriers to intervention uptake included: (1) additional burden for informal caregivers; (2) lack of appropriate workforce to provide guidance; (3) lack of time and financial resources; (4) people with dementia not recognising their diagnosis of dementia and/or a need for support; and (5) stigma. Identified facilitators to intervention uptake included: (1) intervention has potential to fill a large psychological treatment gap in Sweden; (2) objectives and potential benefits understood and agreed by most stakeholders; and (3) some healthcare professionals recognized their potential role in providing intervention guidance.

Conclusions

Several barriers and facilitators for future implementation, specific to the intervention, individuals and families, as well as professionals, were identified during intervention development. Barriers were mapped into evidence-based implementation strategies, which will be adopted to overcome identified barriers. A feasibility study further examining implementation potential, acceptability and feasibility, alongside clinical, methodological, and procedural uncertainties associated with the intervention will be conducted.

Trial registration

Not applicable.
Appendix
Available only for authorised users
Literature
13.
go back to reference Farrand P. Low-Intensity CBT skills and interventions: a practitioners′ manual. London: SAGE Publications Ltd; 2020. Farrand P. Low-Intensity CBT skills and interventions: a practitioners′ manual. London: SAGE Publications Ltd; 2020.
16.
go back to reference Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: a network meta-analysis. JAMA Psychiatry. 2019;17:700–7. https://doi.org/10.1001/jamapsychiatry.2019.0268. [published correction appears in JAMA Psychiatry. 2022 Feb 1;79(2):180]. JAMA Psychiatry. 2019;76(7):700-7.CrossRef Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: a network meta-analysis. JAMA Psychiatry. 2019;17:700–7. https://​doi.​org/​10.​1001/​jamapsychiatry.​2019.​0268. [published correction appears in JAMA Psychiatry. 2022 Feb 1;79(2):180]. JAMA Psychiatry. 2019;76(7):700-7.CrossRef
18.
go back to reference Farrand P, Pentecost C, Greaves C, et al. A written self-help intervention for depressed adults comparing behavioural activation combined with physical activity promotion with a self-help intervention based upon behavioural activation alone: study protocol for a parallel group pilot randomised controlled trial (BAcPAc). Trials. 2014;15:196. https://doi.org/10.1186/1745-6215-15-196.CrossRefPubMedPubMedCentral Farrand P, Pentecost C, Greaves C, et al. A written self-help intervention for depressed adults comparing behavioural activation combined with physical activity promotion with a self-help intervention based upon behavioural activation alone: study protocol for a parallel group pilot randomised controlled trial (BAcPAc). Trials. 2014;15:196. https://​doi.​org/​10.​1186/​1745-6215-15-196.CrossRefPubMedPubMedCentral
23.
go back to reference Farrand P, Woodford J, Llewellyn D, Anderson M, Venkatasubramanian S, Ukoumunne OC, et al. Behavioural activation written self-help to improve mood, wellbeing and quality of life in people with dementia supported by informal carers (PROMOTE): a study protocol for a single-arm feasibility study. Pilot Feasibil Stud. 2016;2:42. https://doi.org/10.1186/s40814-016-0083-x.CrossRef Farrand P, Woodford J, Llewellyn D, Anderson M, Venkatasubramanian S, Ukoumunne OC, et al. Behavioural activation written self-help to improve mood, wellbeing and quality of life in people with dementia supported by informal carers (PROMOTE): a study protocol for a single-arm feasibility study. Pilot Feasibil Stud. 2016;2:42. https://​doi.​org/​10.​1186/​s40814-016-0083-x.CrossRef
24.
go back to reference Farrand P, Woodford J, Small F. Behavioural activation self-help to improve depression in people living with dementia: the promote treatment protocol. NZ J Psychol. 2017;46:51. Farrand P, Woodford J, Small F. Behavioural activation self-help to improve depression in people living with dementia: the promote treatment protocol. NZ J Psychol. 2017;46:51.
70.
72.
go back to reference Wakefield S, Kellett S, Simmonds-Buckley M, Stockton D, Bradbury A, Delgadillo J. Improving Access to Psychological Therapies (IAPT) in the United Kingdom: a systematic review and meta-analysis of 10-years of practice-based evidence. Br J Clin Psychol. 2021;60(1):1–37. https://doi.org/10.1111/bjc.12259.CrossRefPubMed Wakefield S, Kellett S, Simmonds-Buckley M, Stockton D, Bradbury A, Delgadillo J. Improving Access to Psychological Therapies (IAPT) in the United Kingdom: a systematic review and meta-analysis of 10-years of practice-based evidence. Br J Clin Psychol. 2021;60(1):1–37. https://​doi.​org/​10.​1111/​bjc.​12259.CrossRefPubMed
81.
go back to reference Holloway I, Galvin K. Qualitative research in nursing and healthcare (Fourth edition). Chichester: John Wiley & Sons, Ltd; 2016. Holloway I, Galvin K. Qualitative research in nursing and healthcare (Fourth edition). Chichester: John Wiley & Sons, Ltd; 2016.
Metadata
Title
Healthcare and community stakeholders’ perceptions of barriers and facilitators to implementing a behavioral activation intervention for people with dementia and depression: a qualitative study using Normalization Process Theory
Authors
Frida Svedin
Oscar Blomberg
Anders Brantnell
Paul Farrand
Anna Cristina Åberg
Joanne Woodford
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04522-9

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine